[1] Torre LA,Bray F,Siegel RL,et al. Global cancer statistics,2012[J]. Ca Cancer J Clin,2015,65(2):87-108. [2] 钟钏,谭家驹,徐致祥. 食管癌流行病学病因学研究进展[J]. 河南预防医学杂志,2011,22(1):1-17. [3] Ogawa K,Yoshioka Y,Isohashi F,et al. Radiotherapy targeting cancer stem cells:current views and future perspectives[J]. Anticancer Res,2013,33(3):747-754. [4] Chen J,Li Y,Yu TS,et al. A restricted cell population propagates glioblastoma growth after chemotherapy[J]. Nature,2012,488(7412):522-526. [5] Yang YM,Chang JW. Current status and issues in cancer stem cell study[J]. Cancer Invest,2008,26(7):741-755. [6] Huang DZ,Gao QL,Guo LP,et al. Isoltaion and identification of cancer stem-like cells in esophageal carcinoma cell lines[J]. Stem Cells Dev,2009,18(3):465-473. [7] Liu L,Zuo LF,Guo JW. ABCG-2 gene amplification and expression in esophageal cancer cells with acquired adriamycin resistance[J]. Mol Med Rep,2014,9(4):1299-1304. [8] Tsunoda S,Okumura T,Ito T,et al. ABCG2 expression is an independent unfavorable prognostic factor in esophageal squamous cell carcinoma[J]. Oncology,2006,71(3/4):251-258. [9] Wang JL,Yu JP,Sun ZQ,et al. Radiobiological characteristics of cancer stem cells from esophageal cancer cell lines[J]. World J Gastroenterol,2014,20(48):18296-18305. [10] 郑淑妍,陈强,黄小萍,等. CD44及CD44V6在不同分化程度食管癌中的表达水平[J]. 分子诊断与治疗杂志,2013,5(4):232-235. [11] Honing J,Pavlov KV,Mul VE,el at. CD44,SHH and SOX2 as novel biomarkers in esophageal cancer patients treated with neoadjuvant chemoradiotherapy[J]. Radiother Oncol,2015,117(1):152-158. [12] Huang SD,Yuan Y,Liu XH,et al. Self-renewal and chemotherapy resistance of side of P75NTR positive cells in esophageal squamous[J]. BMC Cancer,2009,9(9):9-17. [13] 孙志刚,黄盛东,张宝仁,等. 应用P75NTR分选食管肿瘤干细胞并鉴定其生物学特性[J]. 第二军医大学学报,2009,30(5):480-486. [14] Li S,Yue D,Chen X,et al. Epigenetic regulation of CD271,a potential cancer stem cell marker associated with chemoresistance and metastatic capacity[J]. Oncol Rep,2015,33(1):425-432. [15] Wang JF,Liu Y,Liu WJ,et al. Expression of Bmi-1 gene in esophageal carcinoma cell EC9706 and its effect on cell cycle, apoptosis and migration[J]. Chin J Cancer,2010,29(7):689-696. [16] Zhang Y,Zhang YL,Chen HM,et al. Expression of Bmi-1 and PAL-1 in esophageal squamous cell carcinoma[J]. World J Gastroenterol, 2014,20(18):5533-5539. [17] 黄燕燕,赵生霞,李秋霞,等. 人食管鳞癌Eca109细胞株中肿瘤干细胞的分离鉴定[J]. 石河子大学学报(医学版),2014,32(3):335-339. [18] Vaiphei K,Sinha SK,Kochhar R. Comparative analysis of Oct4 in different histological subtypes of esophageal squamous cell carcinomas in different clinical conditions[J]. Asian Pac J Cancer Prev,2014, 15(8):3519-3524. [19] Li C,Yan Y,Ji W,et al. OCT4 positive regulates survivin expression to promote cell proliferation and leads to poor prognosis in esophageal squamous cell carcinoma[J]. PLoS One,2012,1(11):49693. [20] 苏华芳,万秋燕,邹燕,等. 具干细胞特性食管癌耐放射细胞株基因表达分析[J]. 肿瘤学杂志,2010,16(1):40-45. [21] Wang Y,Zhe H,Gao P,et al. Cancer stem cell marker ALDH1 experession is associated with lymph node metastasis and poor survival in esophageal squamous cell carcinoma:a study from high incidence area of northern China[J]. Dis Esophagus,2012,25(6):560-565. [22] Ajani JA,Wang X,Song S,et al. ALDH-1 expression levels predict response or resistance to preoperative chemoradiation in resectable esophageal cancer patients[J]. Mol Oncol,2014,8(1):142-149. [23] Tanaka M,Kijima H,Shimada H,et al. Expression of podoplanin and vimentin is correlated with prognosis in esophageal squamous cell carcinoma[J]. Mol Med Rep,2015,12(3):4029-4036. [24] Lu C,Xu F,Gu J,et al. Clinical and biological significance of stem-like CD133+ CXCR4+ cells in esophageal squamous cell carcinoma[J]. J Thorac Cardiovasc Surg,2015,150(2):386-395. [25] Sui P,Hu P,Zhang T,et al. High expression of CXCR-2 correlates with lymph node metastasis and predicts unfavorable prognosis in resected esophageal carcinoma[J]. Med Oncol,2014,31(2):809. [26] 邓小峰,王晓博,熊力,等. 胆管癌干细胞的研究进展[J]. 中国普通外科杂志,2015,2(2):265-269. [27] Zhao Y,Bao Q,Schwarz B,et al. Stem cell like side populations in esophageal cancer:a source of chemotherapy resistence and metastases[J]. Stem Cells Dev,2014,23(2):180-192. [28] Chen YL,Li D,Wang DP,et al. Quiescence and attenuated DNA damage response promote survival of esophageal cancer stem cells[J]. J Cell Biochem,2013,113(12):3643-3652. [29] 李步强,慕晓玲. 食管肿瘤干细胞的研究进展[J]. 中国现代医药杂志,2011,13(3):124-125. [30] 崔翔,杨浪,于茜,等. 人食管鳞癌细胞系EC109中肿瘤干细胞的分离(富集)与鉴定[J]. 成都医学院学报,2012,7(3):378-382. [31] Che SM,Zhang XZ,Liu XL,et al. The radiosensitization effect of NS398 on esophaeal cancer stem cell-like radioresistant cells[J]. Dis Esophagus,2011,24(4):265-273. [32] 冉玉格. 人食管鳞癌放射抗性细胞系TE13R120的放射抗性与上皮间皮转化关系的研究[D]. 河北:河北医科大学,2014. [33] 杨延灵,薛晓英,冉玉格,等. 反复照射食管癌放射抗性细胞系方法的重复性和稳定性研究[J]. 河北医科大学学报,2015,36(3):300-303. [34] 苏成海,法逸华,许玉杰,等. 低剂量率γ射线杀伤肿瘤细胞机制的实验研究[J]. 核医学,2006,5(5):362-367. [35] 汪建林,孙志强,于静萍,等. 食管癌细胞株中肿瘤干细胞样细胞的分离培养及生物鉴定[J]. 南京大学学报(自然科学版),2013, 33(10):1362-1367. [36] 李珂,龙辉,王洁莲,等. 钼对人食管癌细胞ECA-109的化疗增敏作用及对食管癌干细胞P75NTR的影响[J]. 世界华人杂志,2012,20(11):959-963. [37] 陈琦,吴清明,程静,等. 冬凌草甲素对食管癌干细胞放射增敏作用的研究[J]. 中国现代医学杂志,2012,22(29):57-60. [38] 刘月姣,李晓敏. 提高食管癌放疗疗效的方法综述[J]. 基层医学论坛,2015,19(7):979-980. [39] 张建华,宋铁牛,李斌,等. 艰难梭菌A毒素对食管癌干细胞损伤的研究[J]. 中国现代医学杂志,2013,23(25):16-19. [40] Huang S,Li XQ,Chen X,et al. Inhibition of microRNA-21 increases radiosensitivity of esophageal cancer cells through phosphatase and tensin homolog deleted on chromosome 10 activation[J]. Dis Esophagus, 2013,26(8):823-831. [41] 赫捷,邵康. 中国食管癌流行病学现状、诊疗现状及未来对策[J]. 中国癌症杂志,2011,27(7):501-504. |